Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference [Yahoo! Finance]
Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Sensei Biotherapeutics, Inc. (NASDAQ: SNSE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.00 price target on the stock.
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference